The prognostic value of circulating lymphocyte counts and ABO blood group in lung cancer stereotactic body radiation therapy: a retrospective study.

Chen, Meng; Chen, Kuifei; Li, Shuling; Meng, Yinnan; Shi, Yangyang; Chen, Xiaofeng; Yang, Haihua

Chen, Meng; Chen, Kuifei; Li, Shuling; Meng, Yinnan; Shi, Yangyang; Chen, Xiaofeng; Yang, Haihua.

Afiliação

Chen M; School of Medicine, Shaoxing University, Shaoxing, China.
Chen K; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China.
Li S; School of Medicine, Shaoxing University, Shaoxing, China.
Meng Y; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China.
Shi Y; School of Medicine, Shaoxing University, Shaoxing, China.
Chen X; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China.
Yang H; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Department of Radiation Oncology, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, China.

J Thorac Dis ; 14(2): 494-506, 2022 Feb.

Article em En | MEDLINE | ID: mdl-35280472

Palavras-chave

ABO blood group; Circulating lymphocyte counts (CLCs); lung cancer; prognostic factors; stereotactic body radiation therapy (SBRT)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google